Wells Fargo
CRBU icon

Wells Fargo’s Caribou Biosciences CRBU Stock Holding History

Wells Fargo’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Sell
298,315
-5,340
-2% -$10.6K ﹤0.01% 4586
2026
Q1 		$577K Buy
303,655
+161,712
+114% +$278K ﹤0.01% 4079
2025
Q4 		$226K Buy
141,943
+116,089
+449% +$244K ﹤0.01% 5009
2025
Q3 		$60.2K Sell
25,854
-61,898
-71% -$117K ﹤0.01% 5499
2025
Q2 		$111K Sell
87,752
-47,128
-35% -$46.4K ﹤0.01% 5127
2025
Q1 		$123K Buy
134,880
+42,892
+47% +$55.7K ﹤0.01% 4990
2024
Q4 		$146K Buy
91,988
+48,759
+113% +$98K ﹤0.01% 4979
2024
Q3 		$84.7K Buy
43,229
+1,622
+4% +$3.32K ﹤0.01% 5116
2024
Q2 		$68.2K Buy
41,607
+6,306
+18% +$20.2K ﹤0.01% 5157
2024
Q1 		$181K Buy
35,301
+8,374
+31% +$51.6K ﹤0.01% 4532
2023
Q4 		$154K Sell
26,927
-85,483
-76% -$423K ﹤0.01% 4632
2023
Q3 		$537K Buy
112,410
+89,054
+381% +$552K ﹤0.01% 3729
2023
Q2 		$99.3K Sell
23,356
-27,210
-54% -$122K ﹤0.01% 5042
2023
Q1 		$269K Buy
50,566
+48,866
+2,874% +$304K ﹤0.01% 4258
2022
Q4 		$10.7K Sell
1,700
-1,061
-38% -$9.44K ﹤0.01% 5526
2022
Q3 		$29K Buy
2,761
+498
+22% +$4.64K ﹤0.01% 5205
2022
Q2 		$13K Sell
2,263
-12,349
-85% -$94.4K ﹤0.01% 5633
2022
Q1 		$134K Sell
14,612
-11,448
-44% -$121K ﹤0.01% 5187
2021
Q4 		$394K Buy
26,060
+24,758
+1,902% +$481K ﹤0.01% 4853
2021
Q3 		$31K Buy
+1,302
New +$31.8K ﹤0.01% 5804

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo's CRBU Position: Q2 2026 in Review

Wells Fargo reduced its Caribou Biosciences (CRBU) stake by 1.8% in Q2 2026, selling an estimated $10.6K and leaving 298,315 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #4586.

Wells Fargo first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $577K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Wells Fargo held 298,315 shares of Caribou Biosciences worth $525K as of Q2 2026.
  • Wells Fargo sold 5,340 Caribou Biosciences shares in Q2 2026, an estimated $10.6K.
  • Caribou Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4586 holding.
  • Wells Fargo first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Wells Fargo's Caribou Biosciences position peaked at $577K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.